Ítem
Solo Metadatos
Therapy for ocular toxoplasmosis
| dc.creator | de-la-Torre, Alejandra | spa |
| dc.creator | Stanford, Miles | spa |
| dc.creator | Curi, Andre | spa |
| dc.creator | Jaffe, Glenn J. | spa |
| dc.creator | Gomez-Marin, Jorge E. | spa |
| dc.date.accessioned | 2020-08-28T15:48:12Z | |
| dc.date.available | 2020-08-28T15:48:12Z | |
| dc.date.created | 2011-10-04 | spa |
| dc.description.abstract | Purpose: To review current evidence for the treatment of ocular toxoplasmosis (OT). Design: Narrative review and expert recommendations. Methods: Meta-analysis and selected original articles from the medical literature were reviewed critically. Expert recommendations were analyzed. Results: Numerous observational studies suggest a benefit of short-term antimicrobial therapy for toxoplasmic retinochoroiditis in immunocompetent patients, although its efficacy has not been proven in randomized clinical trials. A randomized clinical trial revealed that intermittent trimethoprim/sulfamethoxazole treatment could decrease the rate of recurrence in high-risk patients. Intravitreal injection of clindamycin and dexamethasone was an acceptable alternative to the classic treatment for OT in a randomized clinical trial. Conclusions: Opinions about therapy differ and controversy remains about its type, efficacy, and length. Intravitreal therapy may be promising for OT. A recent description of the presence of parasitemia in patients with active and inactive ocular toxoplasmosis raises new questions that need to be explored. | eng |
| dc.format.mimetype | application/pdf | |
| dc.identifier.doi | https://doi.org/10.3109/09273948.2011.608915 | |
| dc.identifier.issn | ISSN: 0927-3948 | |
| dc.identifier.issn | EISSN: 1744-5078 | |
| dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/28441 | |
| dc.language.iso | eng | spa |
| dc.publisher | International Uveitis Study Group | spa |
| dc.publisher | Uveitis Society of India | spa |
| dc.relation.citationEndPage | 320 | |
| dc.relation.citationIssue | No. 5 | |
| dc.relation.citationStartPage | 314 | |
| dc.relation.citationTitle | Ocular Immunology and Inflammation | |
| dc.relation.citationVolume | Vol. 19 | |
| dc.relation.ispartof | Ocular Immunology and Inflammation, ISSN: 0927-3948;EISSN: 1744-5078, Vol. 19, No. 5 (2011); pp. 314-320 | spa |
| dc.relation.uri | https://www.tandfonline.com/doi/abs/10.3109/09273948.2011.608915 | spa |
| dc.rights.accesRights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.acceso | Restringido (Acceso a grupos específicos) | spa |
| dc.source | Ocular Immunology and Inflammation | spa |
| dc.source.instname | instname:Universidad del Rosario | |
| dc.source.reponame | reponame:Repositorio Institucional EdocUR | |
| dc.subject.keyword | Antibiotics | spa |
| dc.subject.keyword | Ocular toxoplasmosis | spa |
| dc.subject.keyword | Recurrences | spa |
| dc.subject.keyword | Steroids | spa |
| dc.subject.keyword | Therapy | spa |
| dc.subject.keyword | Treatment | spa |
| dc.subject.keyword | Uveitis | spa |
| dc.title | Therapy for ocular toxoplasmosis | spa |
| dc.title.TranslatedTitle | Terapia para la toxoplasmosis ocular | spa |
| dc.type | article | eng |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
| dc.type.spa | Artículo | spa |
